Ajax-Loading

Amgen Inc - Short Term Debt

Amgen Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Short-Term-Debt" stands at 2.15 Billion United States Dollars as of 09/30/2025, the lowest value since 03/31/2024.

As of the end of Amgen Inc's third quarter, the item "Short Term Debt" stands at 2.15 Billion USD. This represents a decrease of -11.91 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -39.25 percent compared to the value the year prior.
The 1 year change in percent is -39.25.
The 3 year change in percent is 39.53.
The 5 year change in percent is 2,265.93.
The 10 year change in percent is 72.24.

The Serie's long term average value is 2.15 Billion United States Dollars. It's latest available value, on 09/30/2025, is 0.237 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2013, to it's latest available value, on 09/30/2025, is +30,657.14%.
The Serie's change in percent from it's maximum value, on 06/30/2024, to it's latest available value, on 09/30/2025, is -61.05%.

Short Term Debt for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Short Term Debt905,699,262,464.00
LogoJohnson & Johnson - Short Term Debt486,508,953,600.00
LogoAbbVie Inc - Short Term Debt399,570,305,024.00
LogoRoche Holding AG - Short Term Debt317,433,206,677.55
LogoAstraZeneca PLC - Short Term Debt280,205,508,085.11